SCHEMBL18737177

SCHEMBL18737177

CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC1CCCC(=O)O1

nearest known ligand 0.78

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLCO1B1 Q9Y6L6 4/20 0.78
HMGCR P04035 4/20 0.78
ABCB1 P08183 1/20 0.78
ABCC2 Q92887 1/20 0.78
ABCB11 O95342 3/20 0.58
HDAC1 Q13547 2/20 0.58
HDAC2 Q92769 2/20 0.58
HDAC6 Q9UBN7 2/20 0.58
NR1I2 O75469 1/20 0.58
RHOC P08134 1/20 0.58
CYP3A4 P08684 1/20 0.58
THRB P10828 1/20 0.58
NR1H4 Q96RI1 1/20 0.58
ABCG2 Q9UNQ0 1/20 0.58
ABCC3 O15438 2/20 0.56
ABCC4 O15439 2/20 0.56
SLCO1B3 Q9NPD5 2/20 0.56
PDE6D O43924 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13980905 1.00 SLCO1B1 (0.78) SLCO1B1HMGCRABCB1ABCC2ABCB11
SCHEMBL14605713 0.90 SLCO1B1 (0.62) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL12648491 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL13762456 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL1258955 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL1266 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL1265 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL12060138 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
Atorvastatin Lactone SCHEMBL10025147 0.87 HMGCR (1.00) SLCO1B1HMGCRABCB1ABCC2ABCB11
SCHEMBL13332816 0.87 SLCO1B1 (0.87) SLCO1B1HMGCRABCB1ABCC2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060885-A1 AN IMPROVED PROCESS FOR PREPARATION OF ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LAURUS LABS PRIVATE LIMITED (IN) 2017-04-13 WO disclosed